scispace - formally typeset
M

Melanie Duffield

Researcher at Defence Science and Technology Laboratory

Publications -  13
Citations -  1035

Melanie Duffield is an academic researcher from Defence Science and Technology Laboratory. The author has contributed to research in topics: Yersinia pseudotuberculosis & Antigen. The author has an hindex of 10, co-authored 13 publications receiving 990 citations. Previous affiliations of Melanie Duffield include Centers for Disease Control and Prevention & Salisbury University.

Papers
More filters
Journal ArticleDOI

A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens.

TL;DR: Results show that microarrays allow a more comprehensive analysis of the immune response on an antigen- specific, patient-specific, and population-specific basis, can identify serodiagnostic antigens, and contribute to a more detailed understanding of immunogenicity to this pathogen.
Journal ArticleDOI

Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis.

TL;DR: It is reported that larvae of the wax moth (Galleria mellonella) are susceptible to infection with the human enteropathogen Yersinia pseudotuberculosis at 37 degrees C, and a superoxide dismutase C (sodC) mutant was constructed and tested, showing increased susceptibility to superoxide, a key mechanism of killing in insect haemocytes and mammalian phagocytes.
Journal ArticleDOI

From protein microarrays to diagnostic antigen discovery

TL;DR: Results strongly indicate that the top-ranked antigens can be considered high-priority candidates for diagnostic development, and have direct relevance to rapid, broad-based diagnostic and vaccine development.
Journal ArticleDOI

Predicting conserved essential genes in bacteria: in silico identification of putative drug targets.

TL;DR: A modified down-selection tool is developed to identify essential genes conserved across diverse genera, which can then be used to facilitate the selection of effective targets for novel broad-spectrum antibiotics.